lactitol
Trade name: Pizensy
Small moleculeapproved
Approved
Feb 12, 2020
Lactitol is a disaccharide sugar alcohol produced from lactose. It is used as a replacement bulk sweetener for low calorie foods with 30–40% of the sweetness of sucrose. It is also used medically as a laxative. — Wikipedia
Clinical trial activity
1 trials · 1 clinical orgs · 1 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Feb 24, 2014 (NCT02292121)
Timeline
2020s
- Feb 12, 2020
Braintree Laboratories — Earliest FDA Approval
- Feb 12, 2020
Braintree Laboratories — Marketing Organization
- Feb 12, 2020
Braintree Laboratories — NDA Secondary Org
- Feb 12, 2020
Braintree Laboratories — NDA Organization
Indications
Approved for
Mechanism of action
- ElectrolyteSupplementation
Electrolyte supplementation
Approval history
- approvedFeb 12, 2020
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaLactitol ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02292121 | N/A | Feb 24, 2014 | Assistance Publique - Hôpitaux de Paris |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Assistance Publique - Hôpitaux de Paris | Academic/Hospital | 1 | 1 | 1 | 2014 |
1 organizations
Page 1 / 1
Marketing (3)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| Braintree Laboratories | For profit | MKTG | Feb 12, 2020 |
| Braintree Laboratories | For profit | NDA2 | Feb 12, 2020 |
| Braintree Laboratories | For profit | NDA | Feb 12, 2020 |